Protective effects of Curcuma Longa (Turmeric) on methotrexate induced congestion in portal vein in the liver of albino mice

Farah Deeba; Shehla Khatoon; Ronaq Zaman; Fatima Daud; Sadia Shaukat; Tahira Mehreen

Abstract
Objective: To observe the protective effects of turmeric against methotrexate induced hepatotoxicity.
Methodology: This experimental study included 28 adult male albino mice which were divided into control Group A and experimental Groups, B, C and D. In control Group A, 4 mice, and in Group B, C and D 8 mice were included. To group A, no drug was given. Turmeric extract per oral (400mg /kg) daily was given to Group B for 14 days. Injection methotrexate (40mg/kg) intraperitoneal (I.P) was given to Group C on day 7. Turmeric extract per oral (400mg /kg) daily for 7 days was given to Group D as pre administration to injection methotrexate and on day 7 injection methotrexate (40mg/kg) was given intraperitoneally (I.P) and turmeric extract per oral (400mg/kg) was given for further 7 days daily, post administration to injection methotrexate. All the animals were dissected on day 14 and liver was examined under light microscope to study histological parameters.
Results: The histological examination of liver sections of group A (control) showed normal appearance of portal vein. In Group B (turmeric treated group), no obvious histological changes were observed. Examination of liver tissue of Group C (methotrexate group) showed severe histological changes, which included congestion of portal vein. Group D (methotrexate +turmeric group) showed significant reduction in congestion of portal vein.
Conclusion: This study clearly demonstrates that administration of turmeric (Curcuma Longa) protects liver tissue.

Key words: Turmeric, methotrexate, liver damage, congestion in portal vein, antioxidant.

ABOUT JOURNAL About Publisher Contact Us Editorial & Peer Review Process	POLICIES Privacy Policy Editorial Policy Author's Rights and Obligations Conflict of Interest Policy Plagiarism Policy Advertising Policy	STATEMENTS Terms of Use Author's Rights and Obligations Publication Ethics and Publication Malpractice Statement Protection of Research Participants (Statement On Human And Animal Rights) License Information

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access. The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

Indexed in Scopus, Web of Science, WHO Index Medicus IMEMR, Emromedex, Pakmedinet, ExtraMED and Tehqeeqat

How to cite this article

	Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements